Annexon, Inc.
NASDAQANNX enters the week with a sharp tension at its core: an analyst just doubled his price target while short sellers have quietly built one of the more substantial short positions in small-cap biotech. The most striking move this week came from the Street, not the tape. Needham's Joseph Stringer raised his price target on Annexon from $11 to $25 — more than doubling it — while…
ANNX short interest jumps 20.3% in one week to 16.4% of float, driven by recent clinical trial announcements and analyst coverage initiation.
Snapshot as of 7 Aug 2026
ANNX enters the week with a sharp tension at its core: an analyst just doubled his price target while short sellers have quietly built one of the more substantial short positions in small-cap biotech. The most striking…
Annexon heads into its May 11 earnings report with short sellers at their most committed position in weeks — and options traders beginning to turn cautious. Short interest is the clearest pre-earnings signal here. At…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANNX — free to start on ORTEX.
Sign up for free →Open ANNX on ORTEX